ORACLE HEAD AND NECK CANCER UK LIMITED

Company number

07125497

Status

Active

Incorporation

2010-01-14

Last accounts made up

2024-05-31

Account category

FULL

Primary SIC

86900

Hubs

UK Healthcare

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Goldwins Limited

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Trustees acknowledge that there are material uncertainties related to future income generation and external economic conditions, which may cast doubt on the charity's ability to continue as a going concern.”

Significant events

• “Oracle Head and Neck Cancer continues to deliver on its mission across 4 areas: R (Research). A (Awareness). C (Collaboration). E (Experience of the Patient).”
• “We have approved grants for the following research projects: Audit Feasibility Study, Early Detection and Awareness, Language Impact Study, Laryngeal Cancer Cohort Expansion, Electrical Nerve Stimulation Pilot Project, Investigating Metabolic Reprogramming, The Impact of Paan and Smokeless Tobacco, Boron Neutron Capture Therapy.”
• “Once again, we held a successful Research Impact evening in April at the Tower Suites where guests heard presentations from clinicians and researchers, as well as a presentation from a patient and a family member.”
• “Oracle was invited to collaborate on a cancer awareness leaflet with Roche and the Prison Reform Trust for women prisoners.”
• “We launched our barber shop awareness campaign in Greenwich in collaboration with the Greenwich NHS trust in memory of Robert Shaw.”
• “With the financial support of Macmillan Thames Valley we extended our work on the Sign Away Cancer Campaign.”
• “Thanks to the team at EasyJet, we were able to feature a Head NeckCheck campaign on 20,000 EasyJet Boarding Passes.”
• “Our CEO, along with a patient speaker, attended the Merck Head and Neck Cancer Awareness Day Lunch & Learn on July 25th.”
• “We actively participated in the European Make Sense Campaign, an annual week-long initiative aimed at raising awareness of head and neck cancer across Europe.”
• “One of our patient ambassadors secured us a slot to present to all the military primary care doctors at one of their regular briefings.”
• “To mark Head and Neck Cancer Awareness Day, our team secured PR coverage which reached millions of people.”
• “Our work as a key member of the Head and Neck Cancer Coalition continued. Liaison with new Ministers following the changes in government.”
• “We worked with NHS England to update their HPV, HPV Vaccine and Head and Neck Cancer pages.”
• “We held our annual York Oracle Head and Neck Oncology event in September.”
• “Our incredible Oracle Voices volunteers continued to support PPIE projects, making sure that the patient voice is at the heart of all activities.”
• “We launched a community/participatory theatre project in Leicester to follow up on our community engagement and barriers to diagnosis.”
• “Our CEO, Tamara Khan, worked with the Head and Neck Cancer Coalition to input into the Government consultation on a new 10 year Cancer Strategy.”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers